InMed Pharmaceuticals (INM) Metrics: History & Chart

InMed Pharmaceuticals Inc.(INM)

Drug Manufacturers - Specialty & Generic · Vancouver, BC

$1.330.00 (0.00%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candidate, the company is also developing INM-088, which is undergoing preclinical studies for glaucoma treatment, and INM-405, intended for pain relief. Its broader development pipeline encompasses cannabinoid-based interventions for a variety of medical conditions, with a particular focus on dermatological and ocular disorders. Furthermore, InMed is involved in critical IND-enabling pharmacology and preclinical toxicology research. It is also pioneering IntegraSyn, an innovative integrated biosynthesis approach designed to produce pharmaceutical-grade cannabinoids efficiently. The company maintains a research partnership with BayMedica Inc. to collaborate on the formulation and assessment of novel cannabinoid therapeutics. Established in 1981, the company is headquartered in Vancouver, Canada. It operated under the name Cannabis Technologies Inc. before officially rebranding as InMed Pharmaceuticals Inc. in October 2014.

Vancouver, BC

6 employees

www.inmedpharma.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Eric A. Adams Chem.

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-2.21%
30D Total Return	-3.62%
YTD Total Return	+25.47%
1Y Total Return	-41.92%
3Y Total Return	-90.19%
5Y Total Return	-99.83%
10Y Total Return	-99.95%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+25.47%
2025	-77.64%
2024	-43.03%
2023	-79.41%
2022	-93.83%
2021	-60.18%
2020

CAGR TTM	-41.77%
CAGR 3Y	-53.87%
CAGR 5Y	-71.98%
CAGR 10Y	-52.81%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

INM Valuation Metrics

INM Stock Price Metrics

INM Dividend Metrics

INM Growth Rate Metrics

INM Discounted Cash Flow Metrics

INM Returns By Period

INM Yearly Returns

INM Average Annual Returns By Period (CAGR)

INM Revenue Metrics

INM PE Ratio Metrics

INM PS Ratio Metrics

INM PB Ratio Metrics

INM Price to Free Cash Flow Ratio Metrics

INM Debt to Equity Ratio Metrics

INM PEG Ratio Metrics

INM FCF Yield

INM Earnings Yield

INM EBITDA Yield

INM OCF Yield

INM EV/EBIT Ratio Metrics

INM EV/EBITDA Ratio Metrics

INM EV/Assets Ratio Metrics

INM EV/Sales Ratio Metrics

INM Current Ratio Metrics

INM Quick Ratio Metrics

INM ROIC Metrics

INM Return on Assets Metrics

INM Return on Equity Metrics

INM Net Profit Margin Metrics

INM Gross Profit Margin Metrics

INM Tax Rate Metrics

PS Ratio	0.00
PS Ratio Avg TTM	0.95
PS Ratio Avg 3Y	0.49
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PB Ratio	5.41
PB Ratio Avg TTM	0.48
PB Ratio Avg 3Y	0.21
Current VS TTM Avg	+1027.39%
Current VS 3Y Avg	+2476.00%
Current VS 5Y Avg	+2015.19%

PFCF Ratio	57091.04
PFCF Ratio Avg TTM	41006.18
PFCF Ratio Avg 3Y	41006.18
Current VS TTM Avg	+39.23%
Current VS 3Y Avg	+39.23%
Current VS 5Y Avg	+39.23%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.05
Debt/Equity Ratio Avg 3Y	0.08
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.00%
FCF Yield Avg TTM	0.00%
FCF Yield Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.20
Ev/Assets Ratio Avg TTM	0.16
Ev/Assets Ratio Avg 3Y	0.16
Current VS TTM Avg	+654.23%
Current VS 3Y Avg	+654.23%
Current VS 5Y Avg	+690.53%

Ev/Sales Ratio	0.00
Ev/Sales Ratio Avg TTM	0.29
Ev/Sales Ratio Avg 3Y	0.29
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

Current Ratio	1.37
Current Ratio Avg TTM	4.87
Current Ratio Avg 3Y	5.07
Current VS TTM Avg	-71.90%
Current VS 3Y Avg	-72.97%
Current VS 5Y Avg	-71.31%

Quick Ratio	1.37
Quick Ratio Avg TTM	(88.67)
Quick Ratio Avg 3Y	4.45
Current VS TTM Avg	+101.54%
Current VS 3Y Avg	-69.23%
Current VS 5Y Avg	-67.66%

ROIC	(995.44%)
ROIC Avg 3Y	(53.01%)
ROIC Avg 5Y	(72.12%)
Current VS 3Y Avg	-1777.68%
Current VS 5Y Avg	-1280.28%
Current VS 10Y Avg	-1155.04%

ROA	(414.54%)
ROA Avg TTM	(47.83%)
ROA Avg 3Y	(12.38%)
Current VS TTM Avg	-766.72%
Current VS 3Y Avg	-3249.51%
Current VS 5Y Avg	-2563.02%

ROE	(1168.44%)
ROE Avg TTM	(79.75%)
ROE Avg 3Y	(64.37%)
Current VS TTM Avg	-1365.05%
Current VS 3Y Avg	-1715.21%
Current VS 5Y Avg	-1302.18%

Net Profit Margin	(0.61%)
Net Profit Margin Avg TTM	(107.75%)
Net Profit Margin Avg 3Y	(155.10%)
Current VS TTM Avg	+99.43%
Current VS 3Y Avg	+99.61%
Current VS 5Y Avg	+99.57%

Gross Profit Margin	14.92%
Gross Pft Margin Avg TTM	19.66%
Gross Pft Margin Avg 3Y	26.93%
Current VS TTM Avg	-24.11%
Current VS 3Y Avg	-44.61%
Current VS 5Y Avg	-34.87%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A